PG vs REGN
Procter & Gamble Company (PG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PG currently screens at market cap $373.53B and trailing P/E 25.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PG and REGN stock pages for the full models.
Not investment advice.